Machine Learning for Antibodies Developability Assessment
Time: 2:30 pm
day: Day Two
Details:
- The impact of in-silico approaches to streamline the screening of antibody developability
- Machine learning techniques for rapidly screening early and late-stage biopharmaceutical developability properties.
- Comparison of structural and sequence-based AI models for predicting developability
